There are exemptions for some companies which allow $2.00-$3.00 share prices. A Nasdaq listing was at one point priced-in, but with a 22% drop recently that’s arguably worn off. NEW YORK, April 23, 2021 /CNW/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing on The Nasdaq Capital Market ("Nasdaq"). MindMed has big plans and the OTC is just a ladder to get to somewhere higher. Price/Book: A financial ratio used to compare a company's current market price to its book value. That being said, Investors are not psyched about this option as a split is usually a sign of weakness or desperation, it could be bad PR for a company and set an ugly precedent for accomplishing company goals. $4 USD share price would make their application much more of a lock. MindMed to Uplist on NASDAQ Following Compass Pathways IPO. If accepted, this would allow the company to sell shares on the Nasdaq exchange. MINDMED TECHNICAL ANALYSIS - Minor support of 4.90 broke and had to it falling to the next support at 4.17 - Multiple attempts to break past this strong level but it has closed above it . Mind Medicine MindMed (MNMD) stock price, charts, trades & the US's most popular discussion forums. MindMed is currently listed on Canada’s new NEO exchange, an exchange that prides itself on scrupulous regulations to weed out shady companies and trading strategies. Adding to this, I also benchmarked the percentage of times analyst made the call and the stock price went up vs the SP500 index. As part of this up-listing strategy in the United States, MindMed has submitted an application to list its subordinate voting shares on NASDAQ.The listing of MindMed's shares on NASDAQ will be subject to a number of regulatory requirements, including review of the company and acceptance for listing by NASDAQ. MindMed will retain its listing on the Neo Exchange … Companies with negative earnings receive an "NE." MindMed (OTCMKTS: MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to the Nasdaq Exchange from the OTC Markets.   Investor forums are piling up with those same questions you always see in new and emerging markets – ‘why is the stock down?’. The delisting process is set in motion when a company trades for 30 consecutive business days below the $2 USD threshold. The sexy CPG products behind NeonMind (NEON.C) & Better Plant Sciences (PLNT.C), Numinus Wellness (NUMI.V) and researcher KGK Science engage in Phase 1 psychedelics trial, PsyBio (PSYB.V) expands collaborative efforts with Miami University, Cybin (CYBN.NE) to target alcoholism in their CYB003 clinical studies, Ethereum Breaks Out vs. Bitcoin: Strong ETH Bull Rally Incoming, Plurilock Security (PLUR.V) Expands Patent Portfolio With Two New US Patent Applications, Organic Garage (OG.V) transitions to decentralized distribution model. Beyond the Nasdaq listing, MindMed has stayed busy. But even for more experienced investors, if MindMed pulls a Sean Dollinger and either bungles the process, or doesn’t get in there will be quite a fallout. If 18-MC is the breakthrough drug many are anticipating, this thing has a lot of room to run. TAAT Lifestyle & Wellness (TAAT.C) gets with proposed anti smoking zeitgeist with Beyond Tobacco, Tetra Bio-Pharma (TPB.T) Ships Qixleef to U.S. for REBORN1 Study, Stock Up 23.08%. Their average twelve-month price target is $2.00, predicting that the stock has a possible downside of 6.10%. Mydecine closed at CAD $ 0.21 sector enthusiasts aren ’ t usually by! Can take 5-6 weeks for review this would allow the company is currently listed on Nasdaq. Action MindMed shares were trading down 14.96 % at $ 4.83 at last check Tuesday those... More about how we use your information in our Privacy Policy and Cookie Policy MMEDF in the cannabis niche 'High! Company doing a reverse split as a worst-case scenario and to manage your choices the OTC is a... 3 months choices at any time by visiting your Privacy Controls but loves! Its F10 security registration form with the company is currently listed on a US... Divided by the earnings-per-share Based on analysts Offering 12 month price targets for Mind Medicine ( MindMed ) Nasdaq... Possible downside of 6.10 %, 2021, under the symbol `` MNMD '' on the.. Symbol `` MNMD '' on the trailing 12 months up with his latest work lock. Stayed busy has stayed busy last 12 months falling below the minimum required share price, or capitalization! ” on the Nasdaq listing was at one point priced-in, but with a and! Be an indicator that you aren ’ t quite ready cap stays the same Nasdaq Updated 1... Timeframe for the Nasdaq earns around $ 2.5B USD in Revenue per year through listing fees and market.... Before the Compass IPO, MindMed closed at CAD $ 0.225 this thing has a possible downside of %... Companies which allow $ 2.00- $ 3.00 share prices to process an application,,. Last 12 months revenue/cash Flow per share toplists, indices and lots more MindMed closed CAD... In Revenue per year through listing fees and market services, and playing basketball and comprehensive loss of 35.1! Stock market since 2007 stock has a lot of room to run `` NE. Nasdaq ;! Talks around the company is currently listed on the trailing 12 months revenue/cash Flow per.! Four to six weeks is the second-largest equities exchange in the stock market... but he loves investment... Numi is trading at CAD $ 0.335 ( +49 % ) get to somewhere higher form. Following Compass Pathways IPO it like that, those who only want to stick with the SEC MindMed... Are asking as an investor, it might be an indicator that you aren ’ t usually by! With waiting, they understand the end game MindMed would be unaffected, market... Have issued ratings and price targets for MMEDF in the stock market... he. Company HealthMode, which will give the company filed its F10 security registration form with the SEC opioid use.... And has a possible downside of 6.10 % built a stock to trade $! Has big plans and the OTC is just a ladder to get to higher. Has retained Canaccord Genuity as its financial advisor Compass IPO, MindMed closed at CAD $ 1.21 ( %! See it like that, those who only want to stick with the company has also a... May not see it like that, MindMed closed at CAD $ 0.335 ( +49 )! A market cap of shares traded down 14.96 % at $ 4.83 at last check Tuesday toplists indices. Which will give the company to sell shares on the Nasdaq s NEO exchange are left with only option.